Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Berendt Michael J converted 6,666 Retension Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 13, 2026 · Filed Oct 13, 2026
On Oct 13, 2026, Berendt Michael J (Director) converted 6,666 Retension Pharmaceuticals, Inc. shares, leaving 6,666 shares. Filed Oct 13, 2026 (Form 4).
- Converted
- 6,666 shares
- Holding after
- 6,666 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Stock | Conversion | 4,026 | 4,026 | Direct | |
| Oct 13, 2026 | Common Stock | Conversion | 2,640 | 6,666 | Direct |
Source
Related
- Retension Pharmaceuticals, Inc.
- Berendt Michael J
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Eric Keller · Oct 14, 2026
- Form 4 · Berger Franklin M · Oct 13, 2026